electroCore (NASDAQ:ECOR - Get Free Report) is expected to be releasing its Q2 2025 earnings data after the market closes on Wednesday, August 6th. Analysts expect electroCore to post earnings of ($0.32) per share and revenue of $7.24 million for the quarter.
electroCore (NASDAQ:ECOR - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported ($0.47) EPS for the quarter, beating the consensus estimate of ($0.56) by $0.09. electroCore had a negative net margin of 46.24% and a negative return on equity of 149.04%. The firm had revenue of $6.72 million during the quarter, compared to analyst estimates of $6.93 million. On average, analysts expect electroCore to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.
electroCore Trading Down 2.2%
Shares of ECOR stock traded down $0.15 during trading hours on Friday, hitting $6.77. 51,121 shares of the company were exchanged, compared to its average volume of 112,726. The firm has a fifty day simple moving average of $6.06 and a 200 day simple moving average of $8.96. electroCore has a 52-week low of $4.47 and a 52-week high of $19.49. The stock has a market capitalization of $50.57 million, a price-to-earnings ratio of -4.34 and a beta of 0.26.
Insider Buying and Selling
In other news, Director Thomas J. Errico purchased 10,000 shares of the business's stock in a transaction on Monday, May 12th. The stock was purchased at an average cost of $4.77 per share, with a total value of $47,700.00. Following the acquisition, the director directly owned 266,401 shares in the company, valued at approximately $1,270,732.77. This trade represents a 3.90% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 13.80% of the company's stock.
Institutional Trading of electroCore
Hedge funds have recently made changes to their positions in the stock. Jane Street Group LLC lifted its stake in electroCore by 114.4% in the first quarter. Jane Street Group LLC now owns 36,726 shares of the company's stock worth $246,000 after purchasing an additional 19,599 shares during the last quarter. NewEdge Advisors LLC increased its position in shares of electroCore by 857.9% in the first quarter. NewEdge Advisors LLC now owns 161,955 shares of the company's stock valued at $1,083,000 after acquiring an additional 145,047 shares during the period. Finally, Cubist Systematic Strategies LLC purchased a new position in shares of electroCore in the first quarter valued at about $153,000. 26.74% of the stock is owned by institutional investors.
About electroCore
(
Get Free Report)
electroCore, Inc, a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.
See Also

Before you consider electroCore, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and electroCore wasn't on the list.
While electroCore currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.